Short answer · Medically reviewed summary · Last updated: 2026-05-08
Anencephaly is classified in international medical billing systems under the ICD-10 code Q00.0 and the ICD-9 code 740.0. These codes are used by healthcare providers and insurance systems to identify this specific neural tube defect during prenatal screening and clinical documentation. What exactly is Anencephaly? Anencephaly is a severe, lethal congenital condition characterized by the absence of a major portion of the brain, skull, and scalp.
Anencephaly is classified in international medical billing systems under the ICD-10 code Q00.0 and the ICD-9 code 740.0. These codes are used by healthcare providers and insurance systems to identify this specific neural tube defect during prenatal screening and clinical documentation.
Anencephaly is a severe, lethal congenital condition characterized by the absence of a major portion of the brain, skull, and scalp. It occurs early in fetal development when the cephalic (head) end of the neural tube fails to close, usually between the 23rd and 26th day of gestation. Because the brain tissue remains exposed to amniotic fluid, it undergoes progressive degeneration throughout the pregnancy.
Diagnosis is typically performed through routine prenatal ultrasound, often during the second-trimester anatomy scan. Other methods used to identify Anencephaly include:
For the 31 families in the DiseaseMaps.org community who have navigated a diagnosis of Anencephaly, the emotional burden is profound. Because Anencephaly is a terminal condition, the focus of clinical care shifts toward palliative measures, comfort, and support for the parents. While some infants may breathe briefly or show reflexive movements, vital brain functions cannot be sustained long-term, and the condition is currently considered non-correctable.
Anencephaly is a multifactorial condition, meaning it likely results from a combination of genetic predispositions and environmental factors. While most cases occur sporadically, parents who have had one affected pregnancy have an increased risk (approximately 2-5%) of recurrence in future pregnancies, often related to folate metabolism.
Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment; always seek the advice of your physician regarding a medical condition.